Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Testa

Showing results (121-130 of 187) with videos related to

Pageof 19
Sort By:
Clinical Genitourinary Cancer|October 26, 2019
Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell CarcinomaReza Nejati, Shuanzeng Wei, Robert G Uzzo, et al.
Molecular Cancer Therapeutics|April 26, 2013
Potential role of mTORC2 as a therapeutic target in clear cell carcinoma of the ovaryTakeshi Hisamatsu, Seiji Mabuchi, Yuri Matsumoto, et al.
Cancer Research|February 21, 2016
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 MutationsYuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Disregulated expression of the transcription factor ThPOK during T-cell development leads to high incidence of T-cell lymphomasHyung-Ok Lee, Xiao He, Jayati Mookerjee-Basu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinomaJianming Pei, Harry Cooper, Douglas B Flieder, et al.
Genes, Chromosomes & Cancer|June 17, 2009
Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic miceRoman A Timakhov, Yinfei Tan, Mamta Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancerAhmad L Subhi, Baiqing Tang, Binaifer R Balsara, et al.
The American Journal of Surgical Pathology|August 5, 2021
Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the LiteratureShuanzeng Wei, Alexander Kutikov, Arthur S Patchefsky, et al.
Cancer Research|December 30, 2017
Familial and Somatic <i>BAP1</i> Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent DomainsHongzhuang Peng, Jeremy Prokop, Jayashree Karar, et al.
Cancer Letters|August 22, 2022
BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinomaLauren E Langbein, Rayan El Hajjar, Shen He, et al.
Pageof 19

Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Clinical Genitourinary Cancer|October 26, 2019
Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell CarcinomaReza Nejati, Shuanzeng Wei, Robert G Uzzo, et al.
Molecular Cancer Therapeutics|April 26, 2013
Potential role of mTORC2 as a therapeutic target in clear cell carcinoma of the ovaryTakeshi Hisamatsu, Seiji Mabuchi, Yuri Matsumoto, et al.
Cancer Research|February 21, 2016
Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 MutationsYuwaraj Kadariya, Mitchell Cheung, Jinfei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Disregulated expression of the transcription factor ThPOK during T-cell development leads to high incidence of T-cell lymphomasHyung-Ok Lee, Xiao He, Jayati Mookerjee-Basu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinomaJianming Pei, Harry Cooper, Douglas B Flieder, et al.
Genes, Chromosomes & Cancer|June 17, 2009
Recurrent chromosomal rearrangements implicate oncogenes contributing to T-cell lymphomagenesis in Lck-MyrAkt2 transgenic miceRoman A Timakhov, Yinfei Tan, Mamta Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancerAhmad L Subhi, Baiqing Tang, Binaifer R Balsara, et al.
The American Journal of Surgical Pathology|August 5, 2021
Papillary Renal Neoplasm With Reverse Polarity Is Often Cystic: Report of 7 Cases and Review of 93 Cases in the LiteratureShuanzeng Wei, Alexander Kutikov, Arthur S Patchefsky, et al.
Cancer Research|December 30, 2017
Familial and Somatic <i>BAP1</i> Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent DomainsHongzhuang Peng, Jeremy Prokop, Jayashree Karar, et al.
Cancer Letters|August 22, 2022
BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinomaLauren E Langbein, Rayan El Hajjar, Shen He, et al.
Pageof 19